Lipocine Inc. (LPCN) Financials
LPCN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 23.0 million | 2.6 million |
2023-09-30 | 24.8 million | 2.3 million |
2023-06-30 | 30.5 million | 1.9 million |
2023-03-31 | 34.0 million | 2.1 million |
LPCN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -2.0 million | 153711 |
2023-09-30 | -2.6 million | 158090 |
2023-06-30 | -3.3 million | 164865 |
2023-03-31 | -3.9 million | 177772 |
LPCN Net Income
No data available :(
LPCN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 22.0 million | - | - |
2023-09-30 | 23.8 million | - | - |
2023-06-30 | 25.8 million | - | - |
2023-03-31 | 28.9 million | - | - |
LPCN Shares Outstanding
LPCN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 9167 | 1.7 million | 1.1 million | - |
2023-09-30 | - | 2.9 million | 1.0 million | - |
2023-06-30 | - | 2.5 million | 1.4 million | - |
2023-03-31 | 4000 | 3.1 million | 1.3 million | - |
LPCN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 54997 | 8003 |
2023-09-30 | -3.1 million | 6.0 million |
2023-06-30 | - | 2.5 million |
2023-03-31 | 54990 | 4819 |
LPCN
Price: $4.92
52 week price:
Earnings Per Share: -3.14 USD
P/E Ratio: -1.25
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 27881
Ebitda: -4.8 millionMarket Capitalization: 30.7 million